Expression of MMP-1 in invasive well-differentiated thyroid carcinoma
- PMID: 20652290
- DOI: 10.1007/s00405-010-1343-7
Expression of MMP-1 in invasive well-differentiated thyroid carcinoma
Abstract
The objective of this study is to examine the expression of matrix metalloproteinase 1 (MMP-1) in invasive well-differentiated thyroid carcinoma (WDTC) and its relation to clinicopathological features. This retrospective case study group included 26 patients with invasive WDTC who were treated at our center between January 1985 and May 2007. Clinical data were collected from the medical files. MMP-1 expression was tested in samples from paraffin-embedded tumor by immunohistochemical staining. MMP-1 expression correlated with laryngotracheal invasion (p = 0.032), multifocality of the tumor (p = 0.044), and presence of regional (p = 0.034) and distant metastases (p = 0.048). In conclusion, the expression of MMP-1 in invasive WDTC is consistent with tumor aggressiveness, manifested by laryngotracheal invasion, multifocality, and regional and distant metastases. MMP-1 expression may serve as a prognostic marker and an indicator for the need for more aggressive surgical treatment.
Similar articles
-
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.Int J Cancer. 2009 Aug 15;125(4):894-901. doi: 10.1002/ijc.24462. Int J Cancer. 2009. PMID: 19480010
-
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.BMC Cancer. 2008 Mar 28;8:83. doi: 10.1186/1471-2407-8-83. BMC Cancer. 2008. PMID: 18373849 Free PMC article.
-
Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.World J Surg. 2000 Mar;24(3):334-40. doi: 10.1007/s002689910053. World J Surg. 2000. PMID: 10658069
-
Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):427-35. Eur Rev Med Pharmacol Sci. 2013. PMID: 23467939
-
Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).Eur J Surg Oncol. 2018 Mar;44(3):286-296. doi: 10.1016/j.ejso.2017.07.013. Epub 2017 Aug 3. Eur J Surg Oncol. 2018. PMID: 28801060 Review.
Cited by
-
MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer.Front Oncol. 2022 Nov 21;12:1030590. doi: 10.3389/fonc.2022.1030590. eCollection 2022. Front Oncol. 2022. PMID: 36479070 Free PMC article.
-
Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.Int J Oncol. 2021 Dec;59(6):102. doi: 10.3892/ijo.2021.5282. Epub 2021 Nov 5. Int J Oncol. 2021. PMID: 34738626 Free PMC article.
-
Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.Oncotarget. 2017 Aug 24;8(53):91379-91390. doi: 10.18632/oncotarget.20557. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207651 Free PMC article.
-
Biochemical and Biological Attributes of Matrix Metalloproteinases.Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22. Prog Mol Biol Transl Sci. 2017. PMID: 28413025 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
